Patient Sample Access
Oxford Cancer supports researcher access to biological samples from consented patients with carefully curated patient data.
The infrastructure is flexible and allows for tailored sample collection to the project’s needs and focuses on collecting multiple samples at multiple timepoints from patients with a range of cancers and individuals with conditions at risk of developing these cancers.
All researchers in Oxford are eligible to apply for access to these samples. For information on accessing tissue samples and data, please contact: integrator@medsci.ox.ac.uk.
We collect and store samples in the following areas:
The INTEGRATOR Research Tissue Bank, which is part of the Oxford Cancer Molecular and Cellular Diagnostics Centre, supports ethically approved research by collecting, processing and storing human biological material for defined research purposes.
For information on accessing tissue samples and data through the INTEGRATOR Research Tissue Bank, please email: integrator@medsci.ox.ac.uk.
The Suspected CANcer (SCAN) pathway was designed by Dr Brian Nicholson and Professor Fergus Gleeson to accelerate cancer diagnoses in patients with non-specific cancer symptoms. Patients are referred by their GP to the pathway based in the Churchill Hospital, Oxford, where they are investigated with a whole body computed tomography (CT) scan and undergo blood and stool testing. The outcome of these tests directs the patient to the most appropriate clinical expertise to reach a diagnosis as quickly as possible.
SCAN was the first non-specific symptoms pathway to develop an associated research database including comprehensive imaging, laboratory, and clinical data and biobanking of blood and urine samples.
To apply for access to samples and/or clinical data from the SCAN biobank study, please contact integrator@medsci.ox.ac.uk